Motion Sickness Tablet, Soluble
NDC Package 54973-9147-2
Package Information
Motion Sickness (strychnos nux-vomica seed, tobacco leaf, kerosene, and anamirta cocculus seed) tablets is adultsDissolve 2 to 3 tablets in mouth every 4 hours or as needed. This formulation utilizes a tablet, soluble delivery system. Marketed by Hyland's Consumer Health Inc., this product is identified by NDC 54973-9147.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 54973 - Hyland's Consumer Health Inc.
- 54973-9147 - Motion Sickness
- 54973-9147-2 - 1 BOTTLE, PLASTIC in 1 CARTON / 16 TABLET, SOLUBLE in 1 BOTTLE, PLASTIC
- 54973-9147 - Motion Sickness
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (54973-9147). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54973-9147-2 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 16 tablet, soluble in 1 bottle, plastic of Motion Sickness, a human over the counter drug labeled by Hyland's Consumer Health Inc.. This tablet, soluble is formulated for oral use and contains anamirta cocculus seed; kerosene; strychnos nux-vomica seed; tobacco leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hyland's Consumer Health Inc. on December 01, 1994. The current certification is valid through December 31, 2026.
How is this Hyland's Consumer Health Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54973914702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.